Teleflex Reports Better Than Expected Q4 Earnings, Issues Mixed FY22 Guidance


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Teleflex Incorporated (NYSE:TFX) reported Q4 FY21 revenues of $761.9 million, up 7.1% Y/Y, up 7.9% on a constant currency basis, beating the consensus of $748.63 million.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

  • The revenue growth was attributable to higher sales from Anesthesia and Surgical segments.
  • Adjusted diluted EPS increased 10.8% to $3.60, above the consensus of $3.53.
  • The gross margin improved from 53.9% to 55.1%.
  • Guidance: Teleflex expects FY22 revenue growth of 2.3% to 3.8%, equivalent to $2.87 billion - $2.91 billion, versus the consensus of $2.92 billion. 
  • On a constant currency basis, the Company expects full-year 2022 revenue growth of 4.0% to 5.5%.
  • The Company estimates 2022 adjusted EPS of $13.70 to $14.30, +2.8% - 7.3% Y/Y, compared to the consensus of $14.04.
  • The divestiture of the respiratory assets is estimated to be dilutive to 2022 adjusted earnings per share by $0.17.
  • Price Action: TFX shares are trading at $322.34 during the market session on the last check Thursday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: EarningsNewsGuidanceHealth CareGeneralBriefs